• An efficient vaccine against bovine leukemia virus 

      Gutierrez, Gerónimo; Rodríguez, Sabrina M.; Vilor, Agustín; Gillet, Nicolas A.; DeBrogniez, Alix; Trono, Karina Gabriela; Willems, Luc (BioMed Central, 2015)
      Previous attempts to produce a vaccine against BLV faced problems of efficacy (i.e. only a fraction of animals were protected), persistence (i.e. rapid decrease of immune protection), cost (e.g. production of purified ...
    • Bovine leukemia virus small noncoding RNAs are functional elements that regulate replication and contribute to oncogenesis in vivo 

      Gillet, Nicolas A.; Hamaidia, Malik; Brogniez, Alix de; Gutierrez, Gerónimo; Renotte, Nathalie; Reichert, Michal; Trono, Karina Gabriela; Willems, Luc (2016-04)
      Retroviruses are not expected to encode miRNAs because of the potential problem of self-cleavage of their genomic RNAs. This assumption has recently been challenged by experiments showing that bovine leukemia virus (BLV) ...
    • Vaccination against δ-retroviruses : the bovine leukemia virus paradigm 

      Gutierrez, Gerónimo; Rodriguez, Sabrina M.; de Brogniez, Alix; Gillet, Nicolas A.; Golime, Ramarao; Burny, Arsene; Jaworski, Juan Pablo; Alvarez, Irene; Vagnoni, Lucas Emilio; Trono, Karina Gabriela; Willems, Luc (2014-06)
      Bovine leukemia virus (BLV) and human T-lymphotropic virus type 1 (HTLV-1) are closely related d-retroviruses that induce hematological diseases. HTLV-1 infects about 15 million people worldwide, mainly in subtropical ...